153 related articles for article (PubMed ID: 35241075)
1. Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers.
Qin H; Lu Y; Du L; Shi J; Yin H; Jiang B; Chen W; Diao W; Ding M; Cao W; Qiu X; Zhao X; Guo H
Cancer Cell Int; 2022 Mar; 22(1):101. PubMed ID: 35241075
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis based on weighted gene co-expression network analysis identifies the biomarker utility of lamin B1 in human tumors.
Hua Y; He Z; Zhang X
Cancer Biomark; 2022; 34(1):23-39. PubMed ID: 34511484
[TBL] [Abstract][Full Text] [Related]
3. Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers.
Gong L; Zhong M; Gong K; Wang Z; Zhong Y; Jin Y; Chen H; Tai P; Chen X; Chen A; Cao K
J Inflamm Res; 2023; 16():2297-2315. PubMed ID: 37273485
[TBL] [Abstract][Full Text] [Related]
4. The role of
Cheng L; Zou X; Wang J; Zhang J; Mo Z; Huang H
Front Surg; 2022; 9():1117307. PubMed ID: 36713654
[TBL] [Abstract][Full Text] [Related]
5. LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression.
Gao D; Guo H; Liu Z; Bao L; Li S; Wang Y; Qiu J; Jiang B; Dang X
Curr Cancer Drug Targets; 2024 May; ():. PubMed ID: 38778606
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
[TBL] [Abstract][Full Text] [Related]
7. A pan-cancer analysis of the oncogenic role of Keratin 17 (
Li C; Teng Y; Wu J; Yan F; Deng R; Zhu Y; Li X
Transl Cancer Res; 2021 Oct; 10(10):4489-4501. PubMed ID: 35116305
[TBL] [Abstract][Full Text] [Related]
8. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
[TBL] [Abstract][Full Text] [Related]
9. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
[No Abstract] [Full Text] [Related]
10. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
11. LMNB1 targets FOXD1 to promote progression of prostate cancer.
Huang Y; Zhang L; Liu T; Liang E
Exp Ther Med; 2023 Nov; 26(5):513. PubMed ID: 37840569
[TBL] [Abstract][Full Text] [Related]
12. Research on the oncogenic role of the house-keeping gene
Shen C; Li W; Wang Y
Transl Cancer Res; 2023 Mar; 12(3):525-535. PubMed ID: 37033358
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification.
Qiu Z; Xin M; Wang C; Zhu Y; Kong Q; Liu Z
J Oncol; 2022; 2022():8423173. PubMed ID: 35211173
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis Identified Homologous Recombination Factor With OB-Fold (HROB) as a Potential Biomarker for Various Tumor Types.
Liu X; Wang C
Front Genet; 2022; 13():904060. PubMed ID: 35903352
[No Abstract] [Full Text] [Related]
15. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
Front Immunol; 2021; 12():781087. PubMed ID: 35069553
[TBL] [Abstract][Full Text] [Related]
16. Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response.
Tong W; Wang G; Zhu L; Bai Y; Liu Z; Yang L; Wu H; Cui T; Zhang Y
Front Mol Biosci; 2021; 8():793445. PubMed ID: 35265666
[No Abstract] [Full Text] [Related]
17. Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort.
Principe DR; Narbutis M; Koch R; Rana A
Sci Rep; 2020 Nov; 10(1):20223. PubMed ID: 33214570
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of Dickkopf-1 (DKK1).
Gao S; Jin Y; Zhang H
Front Genet; 2021; 12():757897. PubMed ID: 34899842
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression.
Feng Y; Li F; Yan J; Guo X; Wang F; Shi H; Du J; Zhang H; Gao Y; Li D; Yao Y; Hu W; Han J; Zhang M; Ding R; Wang X; Huang C; Zhang J
Life Sci; 2021 Dec; 287():120056. PubMed ID: 34687756
[TBL] [Abstract][Full Text] [Related]
20. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
